Pedro-de-Lelis F, Garcia-Deltoro M, Ballester-Belda JE, Ortega-Gonzalez E, Herrera-Ballester A, Palmero-da-Cruz J; Interscience Conference on Antimicrobial Agents and Chemotherapy.

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 1996 Sep 15-18; 212 (abstract no. I144).

University General Hospital, Valencia, Spain.

Objective: To analyze the immunological and clinical results of a minimal invasive treatment (partial splenic embolization) for immune thrombocytopenia (IT) treatment related to Human Immunodeficiency Virus (HIV). Method: Inclusion criteria were established to treat IT related to HIV, in order to perform partial splenic artery embolization for splenectomy substitute. Results: From 1994 to 1995, three patients conformed with inclusion criteria, their pre and post embolization hematological values were: (Table: see text) The follow-up time range was from 4 to 18 months (mean 13 months). The procedure had not morbidity but abdominal pain relieved with non-narcotic analgesia. Every patients remained in his previous CDC stage, except one patient who developed pulmonary tuberculosis three months later. There was not immunological deterioration. Conclusions: Partial splenic embolization is a procedure less invasive than splenectomy and is useful and safety for immune thrombocytopenia treatment in selected patients. After one year, patients did not develop immunological worsening.

Publication Types:

• Meeting Abstracts

Keywords:

• Acquired Immunodeficiency Syndrome
• Embolization, Therapeutic
• HIV Infections
• HIV Seropositivity
• Humans
• Spleen
• Splenectomy
• Splenic Artery
• Thrombocytopenia
• methods
• surgery
• therapy

Other ID:

• 98927919

UI: 102235093

From Meeting Abstracts